Get an in-depth insight of one of the leading biotech investors
«Healthcare markets traded higher in July and August, sold off in September and ended the third quarter in line with broader markets»
Dr. Erich Hunziker
BB Biotech invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. It focuses on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit-growth potential.
The renowned Board of Directors of BB Biotech AG has many years of industrial and scientific experience. A team of proven biotech specialists from Bellevue Asset Management AG takes care of investments in the most attractive biotech companies.